REUS NR

Manufacturer: REUS POLSKA SP Z O O
Effective date: 2023-09-15
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 23:56:11

Label at a glance#

ProductREUS NR

Active ingredientNICOTINAMIDE MONONUCLEOTIDE

Label structure13 sections

Storage and handling

Store id a dry place at 15 - 30C (59 - 86F) Avoid excessive heat (greater than 100F) or humidity

Contacts and useful links#

PhoneLabel contact1-855-874-0970

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

NMN (B-Nicotinamide Mononucleotide) 600mg

OTC - DO NOT USE SECTION

1. as aubstitute for sleep. This product is intended for occastional use only.

2. In children under 12 years of age

INACTIVE INGREDIENT SECTION

Rice flour, microcrystalline cellulose, silicon dioxide, magnesium stearate

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of Children.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregrant or breast feeding, ask a health professional before use.

WARNINGS SECTION

Do Not Use

as substitute for sleep. This product is intended for occasional use only.

OTC - QUESTIONS SECTION

Call toll-free 1-855-874-0970 weekdays

STORAGE AND HANDLING SECTION

Store id a dry place at 15 - 30C (59 - 86F)

Avoid excessive heat (greater than 100F) or humidity

WARNINGS AND PRECAUTIONS SECTION

Adults and children 12 years of age and over: take 2 capsules not more often than every 3 to 4 hours

DOSAGE & ADMINISTRATION SECTION

Each capsule contains Quercetin Phytosome 250mb, Trans-Resveratrol 150 mg

INDICATIONS & USAGE SECTION

Adults and children 12 years of age and over: take 2 capsules not more often than every 3 to 4 hours

OTC - PURPOSE SECTION

Helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NaMN

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
83663-003-02	2024-07-30	C162847	48780-1	1030e365-333d-111a-e063-dadaa90a10e2	0562df7b-0bac-a879-e063-6394a90a4087
83663-003-02	2024-01-30	C162847	48780-1	1030e365-333d-111a-e063-dadaa90a10e2	0562df7b-0bac-a879-e063-6394a90a4087

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
83663-003-01	REUS NR	80 in 1 BOTTLE	CAPSULE	80		1
83663-003-02	REUS NR	80 in 1 BOTTLE	CAPSULE	80		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
83663-003	REUS NR CAPSULE [REUS POLSKA SP Z O O]	1	2 package rows	20230916_0562df7b-0bac-a879-e063-6394a90a4087.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

REUS NR
NICOTINAMIDE MONONUCLEOTIDE
RESVERATROL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
83663-003	83663-003-01, 83663-003-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
NICOTINAMIDE MONONUCLEOTIDE	2KG6QX4W0V	ACTIB
RESVERATROL	Q369O8926L	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
0562df7b-0bad-a879-e063-6394a90a4087			0562df7b-0bac-a879-e063-6394a90a4087	2023-09-15	Warnings	Exact identifier spl id: 0562df7b-0bad-a879-e063-6394a90a4087 spl set id: 0562df7b-0bac-a879-e063-6394a90a4087

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.